← Latest news 
Guardant Health partners with Zydus to launch a blood test for early cancer detection in India
Business
Published on 5 May 2026
A single blood draw could screen multiple cancers
Guardant Health plans to launch a new blood-based multi-cancer test in India developed with Zydus Lifesciences. Designed for earlier detection, it can target cancers including lung, breast, and prostate. The move comes as India faces a high cancer burden alongside low routine screening rates, aiming to make screening more accessible and prompt.
- Guardant Health will bring a blood-based cancer test to India
- The test is developed with Zydus Lifesciences
- It is designed for early detection across multiple cancer types
- The rollout targets low screening uptake in India
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times